Semaglutide is a medication that belongs to a class of medicines known as glucagon-like peptide-1 (GLP-1) receptor agonists. It was originally formulated for Type 2 diabetes to help lower blood sugar levels. In higher amounts Semaglutide is used off-label for weight loss.

Semaglutide acts specifically on receptors in the brain's appetite and reward centers, resulting in a marked decrease in appetite, cravings, hunger, and delay in gastric emptying.

Semaglutide not only provides rapid and safe weight loss, but reduces comorbidities such as hypertension, diabetes, and elevated cholesterol, and also offers long-term weight loss maintenance.

Semaglutide is a compounded prescription medication that, when combined with diet and exercise, helps adults with weight management. It is a type of medication called a glucagon-like peptide-1 (GLP-1) agonist, which mimics the hormone GLP-1 that the body naturally produces. Semaglutide works by:

• Lowering blood sugar levels after meals.

• Regulating blood sugar by stimulating glucose-dependent insulin secretion.

• Slowing the release of sugar into your blood, so your body burns more fat.

• Delaying stomach emptying, leaving you feeling fuller longer and limiting overall calorie consumption.

While every individual responds differently to medications, a medical study of 1961 participants demonstrated that in a 68-week period, participants lost an average body weight of ~15%. Furthermore, 1 out of 3 participants lost more than 20% of their body weight.

Adults with a BMI of 30 or more (obesity category).

Adults with a BMI of 27-29 (overweight category), who also have weight-related medical problems such as hypertension, diabetes type 2, or hyperlipidemia.

Candidates must not be allergic to semaglutide and must be willing to follow healthy lifestyle recommendations.

Despite Semaglutide being a good weight loss tool for many people, it's not for everyone. Certain people shouldn't take it, including:

• Pregnant or breastfeeding women

• People with a history of pancreatitis

• People with Type-1 diabetes

• People with an allergy to Semaglutide (or any of its ingredients)

• People with Multiple Endocrine Neoplasia syndrome type 2

• Individuals with a history of thyroid cancer

Always consult a medical professional before taking Semaglutide. Be open and honest about any pre-existing conditions and allergies so your provider can ensure it's a good fit before beginning treatment. Note that the FDA does not approve or monitor compounded medications for safety or efficacy.

Semaglutide can be administered weekly, at any time of day but on the same day each week, with or without meals.

Semaglutide should be injected subcutaneously into upper arms, abdomen or thighs.

History of medullary thyroid cancer

History of gallbladder disease

History of pancreatitis

Multiple endocrine neoplasia syndrome type 2 (MEN2)

Semaglutide is dispensed by our compounded pharmacy and arrives within 4-5 business days.

Several clinical studies show that weekly Semaglutide injections are highly effective at promoting weight loss. In one study, individuals treated with Semaglutide lost an average of 9-13 percent of their body weight over the course of a year when combined with diet and exercise habits.

Most common side effects include nausea, vomiting, stomach upset, diarrhea, tiredness, dizziness, or constipation. These initial side effects usually lessen as you continue to use Semaglutide. In rare cases, it may cause thyroid cancer.

It's crucial to know that Semaglutide results don’t manifest right away. Having realistic expectations and attending all your treatment sessions will increase your chances of satisfactory results. Patients who eat well, exercise, and stick to their treatment plans observe a stunning transformation. Taking before and after photos can help you stay motivated and track your progress.

Semaglutide is ideal for individuals with a body mass index (BMI) of 30 or greater or adults with a BMI of 27 and at least one complication related to body weight, such as hypertension, insulin resistance, high cholesterol, or heart disease.

Most patients will begin to see weight loss after their initial dose has increased one to two times, typically within a month.

Semaglutide is injected just under the skin (subcutaneously), typically in your abdomen.

Unfortunately, we are not accepting insurance for the weight loss program at this time.

We do not offer refunds for orders placed, goods received, and/or services rendered.